Literature DB >> 31189201

Overview of Kybella (Deoxycholic Acid Injection) as a Fat Resorption Product for Submental Fat.

Michael Liu1, Cameron Chesnut2,3, Gary Lask1.   

Abstract

There has been an increasing interest in addressing the issue of submental fat (SMF) when it comes to cosmetic medicine. With the rise of social media, video calls, and the now almost omnipresent accessibility of cameras, there is perhaps now more than ever an emphasis on the facial image. Although invasive procedures such as liposuction and neck lift still play a significant role in reducing SMF, the trend toward minimally invasive methods has finally given rise to a single Food and Drug Administration-approved injectable that is both safe and effective: ATX-101, also known as Kybella in the United States. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31189201     DOI: 10.1055/s-0039-1688943

Source DB:  PubMed          Journal:  Facial Plast Surg        ISSN: 0736-6825            Impact factor:   1.446


  2 in total

1.  Chronic Infection and Nodule Formation following Deoxycholate Injection.

Authors:  Shahab Shahid; Fawaz Al-Hassani
Journal:  Arch Plast Surg       Date:  2022-05-27

Review 2.  The Role of Fat Reducing Agents on Adipocyte Death and Adipose Tissue Inflammation.

Authors:  Ahava Muskat; Megan Pirtle; Yana Kost; Beth N McLellan; Kosaku Shinoda
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-24       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.